Research Spotlight: Tina Iverson

Posted by daviskd2 on Tuesday, January 7, 2020 in News.

CSB Researcher Tina Iverson (Pharmacology) and colleagues have clarified part of the protein kinase MELK’s role in cell cycle signaling. MELK overexpression impacts survival and proliferation of multiple cancer types, so targeting it holds promise as a therapeutic strategy. Read more about this research.